Back to the feed
In brief
On 17.06.2024, a person holding the function "Non-executive member of the board of directors" at Newron Pharmaceuticals S.p.A. disclosed a purchase worth CHF 53’666 to SIX Exchange Regulation.
This is the largest management purchase disclosed at Newron Pharmaceuticals S.p.A. over the previous 12 months (2 purchases in total).
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open
Disclosure detail
A non-executive member of the board of directors of Newron Pharmaceuticals S.p.A. declared a "Purchase" transaction on 17.06.2024.
SIX publishes the manager's function, never their name: no individual is named in management transactions.
Transaction date17.06.2024
Issuing companyNewron Pharmaceuticals S.p.A.
ISINIT0004147952
Transaction sidePurchase
Management functionNon-executive member of the board of directors
Security typeRegistered shares
Quantity5’498
Unit priceCHF 9.76
AmountCHF 53’666
ExchangeXSWX
Notification IDT1O6H00035
Other Newron Pharmaceuticals S.p.A. insider transactions
- Purchase · Executive member of the board of directors / senior management08.10.2026CHF 10’781
- Purchase · Executive member of the board of directors / senior management12.08.2026CHF 23’613
- Purchase · Executive member of the board of directors / senior management11.08.2026CHF 23’962
- Sale · Non-executive member of the board of directors02.12.2025CHF 104’218
- Sale · Non-executive member of the board of directors26.11.2025CHF 247’984
These figures aggregate public disclosures. They are not investment advice.